Cuprina Holdings Faces Nasdaq Delisting Threat Despite Reverse Split, Appeals to Panel
CUPR sits 40% above its 52-week low of $1.76.
Summary
Cuprina Holdings completed its 1-for-8 reverse stock split on May 27th, but this was after the May 26th deadline to regain compliance with Nasdaq's minimum bid price requirement. Consequently, Nasdaq issued a delisting determination, which the company is now appealing to the Hearings Panel. This follows shareholder approval for the reverse split on May 14th, which was intended to bring the company into compliance. The company's Nasdaq listing is at severe risk, and while the appeal process temporarily stays the delisting, the underlying issue of maintaining a $1.00 bid price remains critical. The outcome of the Nasdaq Hearings Panel decision will be crucial.
At the time of this announcement, CUPR was trading at $2.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.3M. The 52-week trading range was $1.76 to $76.00. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.